This country profile provides an overview of Cabo Verde’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
86k people received treatment in Cabo Verde in 2019 51k people did not receive treatment in Cabo Verde in 2019
Cabo Verde does not require mass treatment for elephantiasis.
Cabo Verde does not require mass treatment for blinding trachoma.
Treatment coverage decreased from 70% in 2018 to 63% in 2019.
Pre-sch and school-aged children needing treatment137k
Pre-school and school-aged children receiving treatment86k
Cabo Verde does not require mass treatment for bilharzia.
Cabo Verde does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Cabo Verde.